565 related articles for article (PubMed ID: 17396034)
1. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
Rachmiel M; Rota V; Atenafu E; Daneman D; Hamilton J
Horm Res; 2007; 68(5):236-43. PubMed ID: 17396034
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
Wit JM; Rekers-Mombarg LT; Cutler GB; Crowe B; Beck TJ; Roberts K; Gill A; Chaussain JL; Frisch H; Yturriaga R; Attanasio AF
J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821
[TBL] [Abstract][Full Text] [Related]
3. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
Colmenares A; González L; Gunczler P; Lanes R
J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
[TBL] [Abstract][Full Text] [Related]
5. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
[TBL] [Abstract][Full Text] [Related]
6. Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II).
Binder G; Iliev DI; Mullis PE; Ranke MB
Growth Horm IGF Res; 2007 Jun; 17(3):242-8. PubMed ID: 17360215
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
Korpal-Szczyrska M; Dorant B; Kamińska H; Birkholz D; Niedźwiecki M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859
[TBL] [Abstract][Full Text] [Related]
8. Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: the National Cooperative Growth Study experience.
August GP; Julius JR; Blethen SL
Pediatrics; 1998 Aug; 102(2 Pt 3):512-6. PubMed ID: 9685455
[TBL] [Abstract][Full Text] [Related]
9. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
Bajpai A; Kabra M; Gupta AK; Menon PS
Indian Pediatr; 2006 Jul; 43(7):593-9. PubMed ID: 16891678
[TBL] [Abstract][Full Text] [Related]
10. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
[TBL] [Abstract][Full Text] [Related]
11. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
[TBL] [Abstract][Full Text] [Related]
12. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
Westphal O; Lindberg A;
Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
[TBL] [Abstract][Full Text] [Related]
13. A randomised study of two doses of biosynthetic human growth hormone on final height of pubertal children with growth hormone deficiency.
Coelho R; Brook CG; Preece MA; Stanhope RG; Dattani MT; Hindmarsh PC
Horm Res; 2008; 70(2):85-8. PubMed ID: 18547954
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
Moore WV; Dana K; Frane J; Lippe B
Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
[TBL] [Abstract][Full Text] [Related]
15. Optimizing growth hormone therapy in growth hormone deficient children: what to do in the absence of hard evidence? Commentary on Rachmiel et al.: Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone (Horm Res 2007;68:236-243).
Wit JM
Horm Res; 2007; 68(5):244-7. PubMed ID: 17396035
[No Abstract] [Full Text] [Related]
16. Evaluation of the Final Adult Height and Its Determinants in Patients with Growth Hormone Deficiency: A Single-centre Experience from the South-Eastern Region of Turkey.
Demiral M; Unal E; Baysal B; Baran RT; Demirbilek H; Özbek MN
J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):295-302. PubMed ID: 32157854
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
Kriström B; Aronson AS; Dahlgren J; Gustafsson J; Halldin M; Ivarsson SA; Nilsson NO; Svensson J; Tuvemo T; Albertsson-Wikland K
J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
[TBL] [Abstract][Full Text] [Related]
18. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
19. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
Seminara S; Stagi S; Candura L; Scrivano M; Lenzi L; Nanni L; Pagliai F; Chiarelli F
Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
[TBL] [Abstract][Full Text] [Related]
20. Is GH therapy useful to preserve bone mass in transition-phase patients with GH deficiency?
Aimaretti G; Corneli G; Rovere S; Croce CG; Ghigo E; Procopio M
J Endocrinol Invest; 2005; 28(10 Suppl):28-32. PubMed ID: 16550719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]